The social value of lecanemab for patients with early Alzheimer's disease in Japan.

Saved in:
Bibliographic Details
Title: The social value of lecanemab for patients with early Alzheimer's disease in Japan.
Authors: Igarashi A; Department of Health Policy and Public Health, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Bunkyo-ku, Tokyo, Japan., Azuma-Kasai M; Global AD Value and Access/Patient Advocacy, Eisai Co. Ltd., Bunkyo, Tokyo, Japan., Tani M; Global AD Value and Access/Patient Advocacy, Eisai Co. Ltd., Bunkyo, Tokyo, Japan., Utsumi T; Global AD Value and Access/Patient Advocacy, Eisai Co. Ltd., Bunkyo, Tokyo, Japan., Shibahara H; Health Economics Research Department, CRECON Medical Assessment Inc., Shibuya, Tokyo, Japan., Inoue S; Health Economics Research Department, CRECON Medical Assessment Inc., Shibuya, Tokyo, Japan., Rothwell S; Eisai Europe Ltd., Hatfield, UK., Kamanaka G; Global AD Value and Access/Patient Advocacy, Eisai Co. Ltd., Bunkyo, Tokyo, Japan., Sakata Y; Global AD Value and Access/Patient Advocacy, Eisai Co. Ltd., Bunkyo, Tokyo, Japan., Hiyoshi H; Global AD Value and Access/Patient Advocacy, Eisai Co. Ltd., Bunkyo, Tokyo, Japan., Tomita K; Global AD Value and Access/Patient Advocacy, Eisai Co. Ltd., Bunkyo, Tokyo, Japan.
Source: Journal of Alzheimer's disease : JAD [J Alzheimers Dis] 2026 Jul; Vol. 112 (1), pp. 283-301. Date of Electronic Publication: 2026 May 10.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: SAGE Publications Country of Publication: United States NLM ID: 9814863 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1875-8908 (Electronic) Linking ISSN: 13872877 NLM ISO Abbreviation: J Alzheimers Dis Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42108615
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: The social value of lecanemab for patients with early Alzheimer's disease in Japan.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Igarashi+A%22">Igarashi A</searchLink>; Department of Health Policy and Public Health, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Bunkyo-ku, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Azuma-Kasai+M%22">Azuma-Kasai M</searchLink>; Global AD Value and Access/Patient Advocacy, Eisai Co. Ltd., Bunkyo, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Tani+M%22">Tani M</searchLink>; Global AD Value and Access/Patient Advocacy, Eisai Co. Ltd., Bunkyo, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Utsumi+T%22">Utsumi T</searchLink>; Global AD Value and Access/Patient Advocacy, Eisai Co. Ltd., Bunkyo, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Shibahara+H%22">Shibahara H</searchLink>; Health Economics Research Department, CRECON Medical Assessment Inc., Shibuya, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Inoue+S%22">Inoue S</searchLink>; Health Economics Research Department, CRECON Medical Assessment Inc., Shibuya, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Rothwell+S%22">Rothwell S</searchLink>; Eisai Europe Ltd., Hatfield, UK.<br /><searchLink fieldCode="AU" term="%22Kamanaka+G%22">Kamanaka G</searchLink>; Global AD Value and Access/Patient Advocacy, Eisai Co. Ltd., Bunkyo, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Sakata+Y%22">Sakata Y</searchLink>; Global AD Value and Access/Patient Advocacy, Eisai Co. Ltd., Bunkyo, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Hiyoshi+H%22">Hiyoshi H</searchLink>; Global AD Value and Access/Patient Advocacy, Eisai Co. Ltd., Bunkyo, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Tomita+K%22">Tomita K</searchLink>; Global AD Value and Access/Patient Advocacy, Eisai Co. Ltd., Bunkyo, Tokyo, Japan.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229814863%22">Journal of Alzheimer's disease : JAD</searchLink> [J Alzheimers Dis] 2026 Jul; Vol. 112 (1), pp. 283-301. <i>Date of Electronic Publication: </i>2026 May 10.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22SAGE+Publications%22">SAGE Publications </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9814863 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1875-8908 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2213872877%22">13872877 </searchLink><i>NLM ISO Abbreviation: </i>J Alzheimers Dis <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42108615
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1177/13872877261447312
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 283
    Titles:
      – TitleFull: The social value of lecanemab for patients with early Alzheimer's disease in Japan.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Igarashi A
      – PersonEntity:
          Name:
            NameFull: Azuma-Kasai M
      – PersonEntity:
          Name:
            NameFull: Tani M
      – PersonEntity:
          Name:
            NameFull: Utsumi T
      – PersonEntity:
          Name:
            NameFull: Shibahara H
      – PersonEntity:
          Name:
            NameFull: Inoue S
      – PersonEntity:
          Name:
            NameFull: Rothwell S
      – PersonEntity:
          Name:
            NameFull: Kamanaka G
      – PersonEntity:
          Name:
            NameFull: Sakata Y
      – PersonEntity:
          Name:
            NameFull: Hiyoshi H
      – PersonEntity:
          Name:
            NameFull: Tomita K
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 07
              Text: 2026 Jul
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1875-8908
          Numbering:
            – Type: volume
              Value: 112
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Journal of Alzheimer's disease : JAD
              Type: main
ResultId 1